SCHEMBL13601727

SCHEMBL13601727

CN(C)CCOC(=O)C(=O)N1CCN(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRM3 P20309 1/20 0.43
CHRNA4 P43681 1/20 0.43
MAPT P10636 2/20 0.41
HTR1A P08908 1/20 0.40
GAA P10253 1/20 0.39
CYP1A2 P05177 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
DNM1 Q05193 1/20 0.36
NPC1 O15118 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
BCHE P06276 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601729 0.90 MAPT (0.39) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL12881480 0.88 MAPT (0.43) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL12881488 0.87 ACHE (0.43) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL12881497 0.86 L3MBTL1 (0.44) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL13601693 0.82 MAPT (0.46) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL13601724 0.81 MAPT (0.44) MAPTHTR1AGAACYP1A2TDP1
SCHEMBL12881477 0.79 GNAI3 (0.42) CHRM2CHRM4CHRM1CHRM3MAPT
SCHEMBL12881484 0.79 ACHE (0.41) CHRM2CHRM4CHRM1CHRM3MAPT
SCHEMBL13601726 0.78 SMN1; SMN2 (0.45) MAPTHTR1AGAACYP1A2TDP1
SCHEMBL12881494 0.78 L3MBTL1 (0.42) CHRM2CHRM4CHRM1CHRM3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed